Evaluating the YATAC Programme (YATAC)
The Young Adult Taking Action Program: Protocol for a Pilot Randomized Controlled Trial of Cancer Rehabilitation for Young Adults
Young adults aged 18-39 years with cancer often experience physical, psychological, and social challenges that affect their participation in everyday life and their health-related quality of life. Existing cancer rehabilitation services are rarely tailored to the specific needs of this age group. The Young Adults Taking Action (YATAC) programme was developed together with young adults with cancer, healthcare professionals, and researchers to provide age-specific rehabilitation that supports young adults in managing cancer-related challenges and returning to everyday life.
The aim of this pilot randomized controlled trial is to evaluate the feasibility of conducting a larger trial of the YATAC programme in a municipal rehabilitation setting. The study will examine recruitment, retention, acceptability of randomization, data completeness, assessment burden, and adverse events. In addition, the study will provide preliminary estimates of the programme's effects on health-related quality of life and self-efficacy.
Fifty young adults aged 18-39 years who are undergoing or have completed curative-intent treatment will be recruited through municipal cancer rehabilitation services in Aarhus Municipality, Denmark. Participants will be randomly assigned to receive either the 16-week YATAC programme or usual cancer rehabilitation services. The YATAC programme includes an individual needs assessment and goal setting, followed by group-based and individual sessions addressing physical activity, fatigue, sleep and cognitive challenges, mental health, sexuality and relationships, family and friends, nutrition, and education or work. Outcomes will be assessed at baseline and at 4, 6, and 12 months after enrolment.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Maria Aagesen, PhD
- 전화번호: 004529723294
- 이메일: maagesen@health.sdu.dk
연구 연락처 백업
- 이름: Marc Sampedro Pilegaard, PhD
- 전화번호: 004520722972
- 이메일: masamp@rm.dk
연구 장소
-
-
-
Aarhus, 덴마크, 8000
- 모병
- Folkesundhed (Public Health), the Municipality of Aarhus
-
연락하다:
- Tenna Askjær, Physioterapist and MSc
- 전화번호: 004541859049
- 이메일: tea@aarhus.dk
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
- 성인
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Between 18 and 39 years of age
- Are currently undergoing or have completed curative-intent cancer treatment within the past five years
- Can understand and communicate in Danish and provide informed consent independently
- Have been referred to municipal cancer rehabilitation services in the Municipality of Aarhus
Exclusion Criteria:
- Diagnosed with cancer before the age of 18
- Previously or currently receive rehabilitation
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
활성 비교기: Standard rehabilitation
|
Participants assigned to the control group will receive the standard cancer rehabilitation programme offered through Folkesundhed Aarhus.
This includes physical exercise.
|
|
실험적: YATAC programme
|
The YATAC 2.0 intervention will consist of a 16-week multidimensional rehabilitation programme including a mandatory needs assessment and goal-setting component, which will determine the primarily group-based components in which the young adults will participate. These components will include: 1) Physical activity, 2) Fatigue, sleep, and cognitive challenges, 3) Mental health, 4) Sexuality and relationships, 5) Family and friends, 6) Nutrition, and 7) Education and work. Each participant will be assigned a designated contact person, either a nurse or physiotherapist, who will follow the young adult throughout the programme. The contact person will conduct the needs assessments and goal-setting consultations and contribute to selected group sessions. In addition, one of the contact persons will be present during group-based sessions alongside the primary facilitator to promote continuity, coordination, and a sense of safety throughout the rehabilitation trajectory. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Recruitment rate
기간: Baseline
|
1) Recruitment rate: Number of participants included within the planned recruitment period (July 2026-June 2027).
Data will be collected using screening and recruitment logs completed by a responsible contact professional from the Municipality of Aarhus.
|
Baseline
|
|
Acceptability of randomisation
기간: Baseline
|
2) Acceptability of randomisation: Proportion of randomised participants who accept allocation and commence their assigned study arm.
A contact professional from the Municipality of Aarhus will complete data recruitment and allocation records.
|
Baseline
|
|
Attrition rate
기간: Up to 12 months after baseline
|
3) Attrition rate: Proportion of participants who withdraw during the intervention period.
Data about attrition will be collected using withdrawal registrations and participant records.
|
Up to 12 months after baseline
|
|
Adverse events
기간: Four months after baseline
|
4) Adverse events: Frequency, type, and severity of intervention-related adverse events.
and serious adverse events.
Participants will be asked to self-report intervention-related adverse events and serious adverse events.
|
Four months after baseline
|
|
Completeness of data
기간: Four months after baseline
|
5) Completeness of data collection: Completion of primary patient-reported outcome at primary endpoint.
Questionnaire completion logs will be used.
|
Four months after baseline
|
|
Assessment burden
기간: * Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
6) Assessment burden: Participant-reported burden and acceptability of assessments.
Short evaluation survey completed after assessments using 5-point Likert.
|
* Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Health-related quality of life
기간: * Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
Improvements of the YATAC programme will be evaluated using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). EORTC QLQ-C30 is a cancer-specific and internationally validated instrument consisting of 30 items across 15 domains, including five functional scales, three symptom scales, six single symptom items, and a global health status/quality of life scale. Scores are linearly transformed to a 0-100 scale according to the EORTC scoring manual. Higher scores on functional and global health status scales indicate better functioning and HRQoL, whereas higher symptom scores indicate greater symptom burden. The primary endpoint of the intervention will be global health status/quality of life four months after baseline. The remaining outcomes from the EORTC QLQ-C30 include: physical, role, emotional, cognitive, and social functioning; fatigue; pain; dyspnoea; and insomnia. |
* Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
|
AYA-specific quality of life
기간: * Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
Improvements of the YATAC programme will also be evaluated using the AYA-specific quality of life questionnaire, which is a supplementary module in the EORTC QLQ-AYA30 developed for adolescents and young adults with cancer aged 14-39 years. The questionnaire includes five multi-item scales assessing: 1) Activity limitations, 2) Worry about cancer and the future, 3) Self-esteem, 4) Relationships, and 5) Positive changes. In addition, nine single items address domains such as work/education, romantic and sexual life, relocation, caregiving responsibilities, and diet restrictions. Scores are transformed to a 0-100 scale, where higher scores reflect greater symptom burden, except for positive changes, where higher scores indicate better functioning The outcomes from EORTC QLQ-A include: Activity limitations, worry about cancer and the future, self-esteem, relationships, positive changes, and work/education, romantic and sexual life, relocation. |
* Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
|
Self-Efficacy
기간: * Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
Improvements of the YATAC programme will also be evaluated using the Self-Efficacy for Managing Chronic Disease 6-item Scale (SES6G) consisting of six items rated on a 10-point Likert scale ranging from 1 ("not at all confident") to 10 ("totally confident").
The mean score across items represents the overall self-efficacy score, with higher scores indicating greater confidence in managing health-related challenges.
|
* Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
기타 결과 측정
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Embedded qualitative study
기간: Up to four months baseline
|
An embedded qualitative study will be conducted alongside the pilot RCT to explore barriers and facilitators related to recruitment, participation, retention, and acceptability of participation in rehabilitation intervention trials among young adults with cancer.
|
Up to four months baseline
|
공동 작업자 및 조사자
협력자
협력자
수사관
수사관
- 수석 연구원: Marc Sampedro Pilegaard, PhD, Social Medicine and Rehabilitation, Gødstrup Hospital
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- Young Adult Taking ACtion
- R379-A22563 (기타 보조금/기금 번호: Danish Cancer Society)
- 23-20-0478 (기타 보조금/기금 번호: The Aase and Ejnar Danielsen Foundation)
- R95-A4572 (기타 보조금/기금 번호: The Central Region of Denmark)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
IPD 공유 기간
IPD 공유 액세스 기준
IPD 공유 지원 정보 유형
- 연구_프로토콜
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .